nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—Tamoxifen—pancreatic cancer	0.0665	0.133	CbGbCtD
Tolvaptan—ABCB1—Gemcitabine—pancreatic cancer	0.0573	0.115	CbGbCtD
Tolvaptan—ABCB1—Erlotinib—pancreatic cancer	0.0566	0.113	CbGbCtD
Tolvaptan—ABCB1—Irinotecan—pancreatic cancer	0.0511	0.102	CbGbCtD
Tolvaptan—CYP3A4—Tamoxifen—pancreatic cancer	0.0399	0.0797	CbGbCtD
Tolvaptan—ABCB1—Docetaxel—pancreatic cancer	0.0374	0.0749	CbGbCtD
Tolvaptan—ABCB1—Sunitinib—pancreatic cancer	0.0373	0.0746	CbGbCtD
Tolvaptan—CYP3A4—Erlotinib—pancreatic cancer	0.0339	0.0678	CbGbCtD
Tolvaptan—CYP3A4—Irinotecan—pancreatic cancer	0.0306	0.0612	CbGbCtD
Tolvaptan—ABCB1—Doxorubicin—pancreatic cancer	0.0279	0.0558	CbGbCtD
Tolvaptan—CYP3A4—Docetaxel—pancreatic cancer	0.0224	0.0449	CbGbCtD
Tolvaptan—CYP3A4—Sunitinib—pancreatic cancer	0.0223	0.0447	CbGbCtD
Tolvaptan—CYP3A4—Doxorubicin—pancreatic cancer	0.0167	0.0334	CbGbCtD
Tolvaptan—Vismodegib—SHH—pancreatic cancer	0.0135	1	CrCbGaD
Tolvaptan—Hyponatraemia—Docetaxel—pancreatic cancer	0.000794	0.0029	CcSEcCtD
Tolvaptan—Hyperuricaemia—Epirubicin—pancreatic cancer	0.000792	0.0029	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.00079	0.00289	CcSEcCtD
Tolvaptan—Connective tissue disorder—Irinotecan—pancreatic cancer	0.000777	0.00285	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Epirubicin—pancreatic cancer	0.000777	0.00284	CcSEcCtD
Tolvaptan—Shock—Erlotinib—pancreatic cancer	0.000775	0.00284	CcSEcCtD
Tolvaptan—Nervous system disorder—Erlotinib—pancreatic cancer	0.000773	0.00283	CcSEcCtD
Tolvaptan—Skin disorder—Erlotinib—pancreatic cancer	0.000766	0.0028	CcSEcCtD
Tolvaptan—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.000761	0.00279	CcSEcCtD
Tolvaptan—Anorexia—Tamoxifen—pancreatic cancer	0.000759	0.00278	CcSEcCtD
Tolvaptan—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000757	0.00277	CcSEcCtD
Tolvaptan—Urethral disorder—Gemcitabine—pancreatic cancer	0.000755	0.00276	CcSEcCtD
Tolvaptan—Anorexia—Erlotinib—pancreatic cancer	0.000751	0.00275	CcSEcCtD
Tolvaptan—Blood uric acid increased—Epirubicin—pancreatic cancer	0.000748	0.00274	CcSEcCtD
Tolvaptan—Dehydration—Docetaxel—pancreatic cancer	0.000735	0.00269	CcSEcCtD
Tolvaptan—Pulmonary embolism—Epirubicin—pancreatic cancer	0.000735	0.00269	CcSEcCtD
Tolvaptan—Cardiac disorder—Irinotecan—pancreatic cancer	0.000734	0.00269	CcSEcCtD
Tolvaptan—Hyperuricaemia—Doxorubicin—pancreatic cancer	0.000733	0.00268	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.000722	0.00264	CcSEcCtD
Tolvaptan—Hyperkalaemia—Epirubicin—pancreatic cancer	0.000722	0.00264	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Doxorubicin—pancreatic cancer	0.000719	0.00263	CcSEcCtD
Tolvaptan—Angiopathy—Irinotecan—pancreatic cancer	0.000718	0.00263	CcSEcCtD
Tolvaptan—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000715	0.00262	CcSEcCtD
Tolvaptan—Immune system disorder—Irinotecan—pancreatic cancer	0.000715	0.00262	CcSEcCtD
Tolvaptan—Breast disorder—Docetaxel—pancreatic cancer	0.000714	0.00261	CcSEcCtD
Tolvaptan—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000713	0.00261	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.000712	0.00261	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000707	0.00259	CcSEcCtD
Tolvaptan—Angiopathy—Gemcitabine—pancreatic cancer	0.000699	0.00256	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.000697	0.00255	CcSEcCtD
Tolvaptan—Dry mouth—Sunitinib—pancreatic cancer	0.000696	0.00255	CcSEcCtD
Tolvaptan—Immune system disorder—Gemcitabine—pancreatic cancer	0.000696	0.00255	CcSEcCtD
Tolvaptan—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000694	0.00254	CcSEcCtD
Tolvaptan—Decreased appetite—Tamoxifen—pancreatic cancer	0.000693	0.00253	CcSEcCtD
Tolvaptan—Blood uric acid increased—Doxorubicin—pancreatic cancer	0.000692	0.00253	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000688	0.00252	CcSEcCtD
Tolvaptan—Decreased appetite—Erlotinib—pancreatic cancer	0.000685	0.00251	CcSEcCtD
Tolvaptan—Constipation—Tamoxifen—pancreatic cancer	0.000681	0.00249	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00068	0.00249	CcSEcCtD
Tolvaptan—Pulmonary embolism—Doxorubicin—pancreatic cancer	0.00068	0.00249	CcSEcCtD
Tolvaptan—Constipation—Erlotinib—pancreatic cancer	0.000674	0.00247	CcSEcCtD
Tolvaptan—Shock—Sunitinib—pancreatic cancer	0.000671	0.00246	CcSEcCtD
Tolvaptan—Nervous system disorder—Sunitinib—pancreatic cancer	0.000669	0.00245	CcSEcCtD
Tolvaptan—Hyperkalaemia—Doxorubicin—pancreatic cancer	0.000668	0.00244	CcSEcCtD
Tolvaptan—Ecchymosis—Epirubicin—pancreatic cancer	0.000664	0.00243	CcSEcCtD
Tolvaptan—Skin disorder—Sunitinib—pancreatic cancer	0.000663	0.00243	CcSEcCtD
Tolvaptan—Anorexia—Sunitinib—pancreatic cancer	0.00065	0.00238	CcSEcCtD
Tolvaptan—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000639	0.00234	CcSEcCtD
Tolvaptan—Body temperature increased—Erlotinib—pancreatic cancer	0.000623	0.00228	CcSEcCtD
Tolvaptan—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000622	0.00228	CcSEcCtD
Tolvaptan—Malaise—Irinotecan—pancreatic cancer	0.000621	0.00227	CcSEcCtD
Tolvaptan—Syncope—Irinotecan—pancreatic cancer	0.000618	0.00226	CcSEcCtD
Tolvaptan—Ecchymosis—Doxorubicin—pancreatic cancer	0.000614	0.00225	CcSEcCtD
Tolvaptan—Loss of consciousness—Irinotecan—pancreatic cancer	0.000605	0.00222	CcSEcCtD
Tolvaptan—Malaise—Gemcitabine—pancreatic cancer	0.000605	0.00221	CcSEcCtD
Tolvaptan—Renal failure—Docetaxel—pancreatic cancer	0.000599	0.00219	CcSEcCtD
Tolvaptan—Decreased appetite—Sunitinib—pancreatic cancer	0.000593	0.00217	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000589	0.00216	CcSEcCtD
Tolvaptan—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000587	0.00215	CcSEcCtD
Tolvaptan—Constipation—Sunitinib—pancreatic cancer	0.000583	0.00214	CcSEcCtD
Tolvaptan—Discomfort—Irinotecan—pancreatic cancer	0.000579	0.00212	CcSEcCtD
Tolvaptan—Asthenia—Tamoxifen—pancreatic cancer	0.000572	0.00209	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000567	0.00208	CcSEcCtD
Tolvaptan—Asthenia—Erlotinib—pancreatic cancer	0.000565	0.00207	CcSEcCtD
Tolvaptan—Discomfort—Gemcitabine—pancreatic cancer	0.000564	0.00207	CcSEcCtD
Tolvaptan—Pruritus—Tamoxifen—pancreatic cancer	0.000564	0.00206	CcSEcCtD
Tolvaptan—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000562	0.00206	CcSEcCtD
Tolvaptan—Renal impairment—Epirubicin—pancreatic cancer	0.00056	0.00205	CcSEcCtD
Tolvaptan—Pruritus—Erlotinib—pancreatic cancer	0.000558	0.00204	CcSEcCtD
Tolvaptan—Discomfort—Fluorouracil—pancreatic cancer	0.000555	0.00203	CcSEcCtD
Tolvaptan—Shock—Irinotecan—pancreatic cancer	0.000553	0.00202	CcSEcCtD
Tolvaptan—Nervous system disorder—Irinotecan—pancreatic cancer	0.000551	0.00202	CcSEcCtD
Tolvaptan—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000547	0.002	CcSEcCtD
Tolvaptan—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000546	0.002	CcSEcCtD
Tolvaptan—Diarrhoea—Tamoxifen—pancreatic cancer	0.000545	0.00199	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000544	0.00199	CcSEcCtD
Tolvaptan—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00054	0.00198	CcSEcCtD
Tolvaptan—Body temperature increased—Sunitinib—pancreatic cancer	0.000539	0.00197	CcSEcCtD
Tolvaptan—Diarrhoea—Erlotinib—pancreatic cancer	0.000539	0.00197	CcSEcCtD
Tolvaptan—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000538	0.00197	CcSEcCtD
Tolvaptan—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000537	0.00197	CcSEcCtD
Tolvaptan—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000537	0.00197	CcSEcCtD
Tolvaptan—Urethral disorder—Docetaxel—pancreatic cancer	0.000536	0.00196	CcSEcCtD
Tolvaptan—Anorexia—Irinotecan—pancreatic cancer	0.000536	0.00196	CcSEcCtD
Tolvaptan—Hyponatraemia—Epirubicin—pancreatic cancer	0.000535	0.00196	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000533	0.00195	CcSEcCtD
Tolvaptan—Skin disorder—Gemcitabine—pancreatic cancer	0.000532	0.00195	CcSEcCtD
Tolvaptan—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000528	0.00193	CcSEcCtD
Tolvaptan—Dizziness—Tamoxifen—pancreatic cancer	0.000527	0.00193	CcSEcCtD
Tolvaptan—Anorexia—Gemcitabine—pancreatic cancer	0.000522	0.00191	CcSEcCtD
Tolvaptan—Dizziness—Erlotinib—pancreatic cancer	0.000521	0.00191	CcSEcCtD
Tolvaptan—Renal impairment—Doxorubicin—pancreatic cancer	0.000518	0.0019	CcSEcCtD
Tolvaptan—Anorexia—Fluorouracil—pancreatic cancer	0.000513	0.00188	CcSEcCtD
Tolvaptan—Cardiac disorder—Docetaxel—pancreatic cancer	0.000508	0.00186	CcSEcCtD
Tolvaptan—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000506	0.00185	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000503	0.00184	CcSEcCtD
Tolvaptan—Hypersensitivity—Sunitinib—pancreatic cancer	0.000503	0.00184	CcSEcCtD
Tolvaptan—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000499	0.00183	CcSEcCtD
Tolvaptan—Headache—Tamoxifen—pancreatic cancer	0.000499	0.00183	CcSEcCtD
Tolvaptan—Angiopathy—Docetaxel—pancreatic cancer	0.000496	0.00182	CcSEcCtD
Tolvaptan—Dehydration—Epirubicin—pancreatic cancer	0.000496	0.00181	CcSEcCtD
Tolvaptan—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000495	0.00181	CcSEcCtD
Tolvaptan—Immune system disorder—Docetaxel—pancreatic cancer	0.000494	0.00181	CcSEcCtD
Tolvaptan—Headache—Erlotinib—pancreatic cancer	0.000494	0.00181	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000493	0.00181	CcSEcCtD
Tolvaptan—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000493	0.0018	CcSEcCtD
Tolvaptan—Asthenia—Sunitinib—pancreatic cancer	0.00049	0.00179	CcSEcCtD
Tolvaptan—Decreased appetite—Irinotecan—pancreatic cancer	0.000489	0.00179	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000487	0.00178	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000485	0.00178	CcSEcCtD
Tolvaptan—Pruritus—Sunitinib—pancreatic cancer	0.000483	0.00177	CcSEcCtD
Tolvaptan—Breast disorder—Epirubicin—pancreatic cancer	0.000482	0.00176	CcSEcCtD
Tolvaptan—Constipation—Irinotecan—pancreatic cancer	0.000481	0.00176	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.00048	0.00176	CcSEcCtD
Tolvaptan—Malnutrition—Docetaxel—pancreatic cancer	0.000476	0.00174	CcSEcCtD
Tolvaptan—Decreased appetite—Gemcitabine—pancreatic cancer	0.000476	0.00174	CcSEcCtD
Tolvaptan—Nausea—Tamoxifen—pancreatic cancer	0.000473	0.00173	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000473	0.00173	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.00047	0.00172	CcSEcCtD
Tolvaptan—Constipation—Gemcitabine—pancreatic cancer	0.000468	0.00171	CcSEcCtD
Tolvaptan—Nausea—Erlotinib—pancreatic cancer	0.000468	0.00171	CcSEcCtD
Tolvaptan—Decreased appetite—Fluorouracil—pancreatic cancer	0.000468	0.00171	CcSEcCtD
Tolvaptan—Diarrhoea—Sunitinib—pancreatic cancer	0.000467	0.00171	CcSEcCtD
Tolvaptan—Dysgeusia—Docetaxel—pancreatic cancer	0.000466	0.00171	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000465	0.0017	CcSEcCtD
Tolvaptan—Feeling abnormal—Irinotecan—pancreatic cancer	0.000463	0.0017	CcSEcCtD
Tolvaptan—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000462	0.00169	CcSEcCtD
Tolvaptan—Dehydration—Doxorubicin—pancreatic cancer	0.000459	0.00168	CcSEcCtD
Tolvaptan—Dizziness—Sunitinib—pancreatic cancer	0.000451	0.00165	CcSEcCtD
Tolvaptan—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000451	0.00165	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000451	0.00165	CcSEcCtD
Tolvaptan—Breast disorder—Doxorubicin—pancreatic cancer	0.000446	0.00163	CcSEcCtD
Tolvaptan—Body temperature increased—Irinotecan—pancreatic cancer	0.000444	0.00163	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000444	0.00163	CcSEcCtD
Tolvaptan—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000444	0.00162	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000435	0.00159	CcSEcCtD
Tolvaptan—Body temperature increased—Gemcitabine—pancreatic cancer	0.000433	0.00158	CcSEcCtD
Tolvaptan—Headache—Sunitinib—pancreatic cancer	0.000427	0.00156	CcSEcCtD
Tolvaptan—Syncope—Docetaxel—pancreatic cancer	0.000427	0.00156	CcSEcCtD
Tolvaptan—Pollakiuria—Epirubicin—pancreatic cancer	0.000426	0.00156	CcSEcCtD
Tolvaptan—Body temperature increased—Fluorouracil—pancreatic cancer	0.000426	0.00156	CcSEcCtD
Tolvaptan—Loss of consciousness—Docetaxel—pancreatic cancer	0.000418	0.00153	CcSEcCtD
Tolvaptan—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000416	0.00152	CcSEcCtD
Tolvaptan—Hypersensitivity—Irinotecan—pancreatic cancer	0.000414	0.00152	CcSEcCtD
Tolvaptan—Nausea—Sunitinib—pancreatic cancer	0.000405	0.00148	CcSEcCtD
Tolvaptan—Renal failure—Epirubicin—pancreatic cancer	0.000404	0.00148	CcSEcCtD
Tolvaptan—Asthenia—Irinotecan—pancreatic cancer	0.000403	0.00148	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000402	0.00147	CcSEcCtD
Tolvaptan—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000397	0.00145	CcSEcCtD
Tolvaptan—Dry mouth—Docetaxel—pancreatic cancer	0.000396	0.00145	CcSEcCtD
Tolvaptan—Pollakiuria—Doxorubicin—pancreatic cancer	0.000394	0.00144	CcSEcCtD
Tolvaptan—Asthenia—Gemcitabine—pancreatic cancer	0.000393	0.00144	CcSEcCtD
Tolvaptan—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000389	0.00142	CcSEcCtD
Tolvaptan—Pruritus—Gemcitabine—pancreatic cancer	0.000387	0.00142	CcSEcCtD
Tolvaptan—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000385	0.00141	CcSEcCtD
Tolvaptan—Diarrhoea—Irinotecan—pancreatic cancer	0.000385	0.00141	CcSEcCtD
Tolvaptan—Shock—Docetaxel—pancreatic cancer	0.000382	0.0014	CcSEcCtD
Tolvaptan—Nervous system disorder—Docetaxel—pancreatic cancer	0.000381	0.00139	CcSEcCtD
Tolvaptan—Pruritus—Fluorouracil—pancreatic cancer	0.000381	0.00139	CcSEcCtD
Tolvaptan—Skin disorder—Docetaxel—pancreatic cancer	0.000377	0.00138	CcSEcCtD
Tolvaptan—Diarrhoea—Gemcitabine—pancreatic cancer	0.000375	0.00137	CcSEcCtD
Tolvaptan—Renal failure—Doxorubicin—pancreatic cancer	0.000374	0.00137	CcSEcCtD
Tolvaptan—Dizziness—Irinotecan—pancreatic cancer	0.000372	0.00136	CcSEcCtD
Tolvaptan—Anorexia—Docetaxel—pancreatic cancer	0.00037	0.00136	CcSEcCtD
Tolvaptan—Diarrhoea—Fluorouracil—pancreatic cancer	0.000368	0.00135	CcSEcCtD
Tolvaptan—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000364	0.00133	CcSEcCtD
Tolvaptan—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000362	0.00133	CcSEcCtD
Tolvaptan—Urethral disorder—Epirubicin—pancreatic cancer	0.000362	0.00132	CcSEcCtD
Tolvaptan—Dizziness—Fluorouracil—pancreatic cancer	0.000356	0.0013	CcSEcCtD
Tolvaptan—Headache—Irinotecan—pancreatic cancer	0.000352	0.00129	CcSEcCtD
Tolvaptan—Headache—Gemcitabine—pancreatic cancer	0.000343	0.00126	CcSEcCtD
Tolvaptan—Cardiac disorder—Epirubicin—pancreatic cancer	0.000342	0.00125	CcSEcCtD
Tolvaptan—Decreased appetite—Docetaxel—pancreatic cancer	0.000338	0.00124	CcSEcCtD
Tolvaptan—Headache—Fluorouracil—pancreatic cancer	0.000337	0.00123	CcSEcCtD
Tolvaptan—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000337	0.00123	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000335	0.00123	CcSEcCtD
Tolvaptan—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000335	0.00123	CcSEcCtD
Tolvaptan—Angiopathy—Epirubicin—pancreatic cancer	0.000335	0.00122	CcSEcCtD
Tolvaptan—Urethral disorder—Doxorubicin—pancreatic cancer	0.000335	0.00122	CcSEcCtD
Tolvaptan—Nausea—Irinotecan—pancreatic cancer	0.000334	0.00122	CcSEcCtD
Tolvaptan—Immune system disorder—Epirubicin—pancreatic cancer	0.000333	0.00122	CcSEcCtD
Tolvaptan—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000332	0.00122	CcSEcCtD
Tolvaptan—Constipation—Docetaxel—pancreatic cancer	0.000332	0.00122	CcSEcCtD
Tolvaptan—Nausea—Gemcitabine—pancreatic cancer	0.000325	0.00119	CcSEcCtD
Tolvaptan—Malnutrition—Epirubicin—pancreatic cancer	0.000321	0.00118	CcSEcCtD
Tolvaptan—Feeling abnormal—Docetaxel—pancreatic cancer	0.00032	0.00117	CcSEcCtD
Tolvaptan—Nausea—Fluorouracil—pancreatic cancer	0.00032	0.00117	CcSEcCtD
Tolvaptan—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000317	0.00116	CcSEcCtD
Tolvaptan—Dysgeusia—Epirubicin—pancreatic cancer	0.000314	0.00115	CcSEcCtD
Tolvaptan—Angiopathy—Doxorubicin—pancreatic cancer	0.00031	0.00113	CcSEcCtD
Tolvaptan—Immune system disorder—Doxorubicin—pancreatic cancer	0.000308	0.00113	CcSEcCtD
Tolvaptan—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000308	0.00113	CcSEcCtD
Tolvaptan—Body temperature increased—Docetaxel—pancreatic cancer	0.000307	0.00112	CcSEcCtD
Tolvaptan—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000298	0.00109	CcSEcCtD
Tolvaptan—Malnutrition—Doxorubicin—pancreatic cancer	0.000297	0.00109	CcSEcCtD
Tolvaptan—Dysgeusia—Doxorubicin—pancreatic cancer	0.000291	0.00106	CcSEcCtD
Tolvaptan—Malaise—Epirubicin—pancreatic cancer	0.00029	0.00106	CcSEcCtD
Tolvaptan—Syncope—Epirubicin—pancreatic cancer	0.000288	0.00105	CcSEcCtD
Tolvaptan—Hypersensitivity—Docetaxel—pancreatic cancer	0.000286	0.00105	CcSEcCtD
Tolvaptan—Loss of consciousness—Epirubicin—pancreatic cancer	0.000282	0.00103	CcSEcCtD
Tolvaptan—Asthenia—Docetaxel—pancreatic cancer	0.000279	0.00102	CcSEcCtD
Tolvaptan—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000276	0.00101	CcSEcCtD
Tolvaptan—Pruritus—Docetaxel—pancreatic cancer	0.000275	0.00101	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000271	0.000994	CcSEcCtD
Tolvaptan—Discomfort—Epirubicin—pancreatic cancer	0.00027	0.000989	CcSEcCtD
Tolvaptan—Malaise—Doxorubicin—pancreatic cancer	0.000268	0.000981	CcSEcCtD
Tolvaptan—Dry mouth—Epirubicin—pancreatic cancer	0.000267	0.000979	CcSEcCtD
Tolvaptan—Syncope—Doxorubicin—pancreatic cancer	0.000266	0.000975	CcSEcCtD
Tolvaptan—Diarrhoea—Docetaxel—pancreatic cancer	0.000266	0.000973	CcSEcCtD
Tolvaptan—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000262	0.000959	CcSEcCtD
Tolvaptan—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000261	0.000956	CcSEcCtD
Tolvaptan—Shock—Epirubicin—pancreatic cancer	0.000258	0.000944	CcSEcCtD
Tolvaptan—Nervous system disorder—Epirubicin—pancreatic cancer	0.000257	0.000941	CcSEcCtD
Tolvaptan—Dizziness—Docetaxel—pancreatic cancer	0.000257	0.00094	CcSEcCtD
Tolvaptan—Skin disorder—Epirubicin—pancreatic cancer	0.000255	0.000932	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000251	0.000919	CcSEcCtD
Tolvaptan—Discomfort—Doxorubicin—pancreatic cancer	0.00025	0.000915	CcSEcCtD
Tolvaptan—Anorexia—Epirubicin—pancreatic cancer	0.00025	0.000914	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—PPY—pancreatic cancer	0.000247	0.00116	CbGpPWpGaD
Tolvaptan—Dry mouth—Doxorubicin—pancreatic cancer	0.000247	0.000905	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—SSTR2—pancreatic cancer	0.000245	0.00115	CbGpPWpGaD
Tolvaptan—Headache—Docetaxel—pancreatic cancer	0.000243	0.000891	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—SSTR2—pancreatic cancer	0.000243	0.00114	CbGpPWpGaD
Tolvaptan—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000242	0.000887	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CNR1—pancreatic cancer	0.00024	0.00112	CbGpPWpGaD
Tolvaptan—Shock—Doxorubicin—pancreatic cancer	0.000239	0.000873	CcSEcCtD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	0.000238	0.00112	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000238	0.00112	CbGpPWpGaD
Tolvaptan—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000238	0.00087	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—CCKBR—pancreatic cancer	0.000236	0.00111	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—SST—pancreatic cancer	0.000236	0.00111	CbGpPWpGaD
Tolvaptan—Skin disorder—Doxorubicin—pancreatic cancer	0.000236	0.000862	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000235	0.0011	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCKBR—pancreatic cancer	0.000235	0.0011	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—SST—pancreatic cancer	0.000234	0.0011	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000233	0.00109	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000232	0.00109	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—GCG—pancreatic cancer	0.000231	0.00108	CbGpPWpGaD
Tolvaptan—Anorexia—Doxorubicin—pancreatic cancer	0.000231	0.000846	CcSEcCtD
Tolvaptan—Nausea—Docetaxel—pancreatic cancer	0.000231	0.000845	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—GCG—pancreatic cancer	0.00023	0.00108	CbGpPWpGaD
Tolvaptan—Decreased appetite—Epirubicin—pancreatic cancer	0.000228	0.000834	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000226	0.000828	CcSEcCtD
Tolvaptan—AVPR1A—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000225	0.00106	CbGpPWpGaD
Tolvaptan—Constipation—Epirubicin—pancreatic cancer	0.000224	0.00082	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—DTX4—pancreatic cancer	0.000222	0.00104	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GLI1—pancreatic cancer	0.000222	0.00104	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000221	0.00103	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GLI1—pancreatic cancer	0.000221	0.00103	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DTX4—pancreatic cancer	0.000221	0.00103	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000219	0.00103	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000219	0.00103	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000218	0.00102	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CNR1—pancreatic cancer	0.000218	0.00102	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NRP1—pancreatic cancer	0.000216	0.00101	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000216	0.00101	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CNR1—pancreatic cancer	0.000216	0.00101	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Epirubicin—pancreatic cancer	0.000216	0.00079	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—NRP1—pancreatic cancer	0.000215	0.00101	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000215	0.00101	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000214	0.001	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000212	0.000994	CbGpPWpGaD
Tolvaptan—Decreased appetite—Doxorubicin—pancreatic cancer	0.000211	0.000771	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—GCG—pancreatic cancer	0.00021	0.000985	CbGpPWpGaD
Tolvaptan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000209	0.000766	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—GCG—pancreatic cancer	0.000209	0.000978	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HEY2—pancreatic cancer	0.000208	0.000975	CbGpPWpGaD
Tolvaptan—Constipation—Doxorubicin—pancreatic cancer	0.000207	0.000759	CcSEcCtD
Tolvaptan—Body temperature increased—Epirubicin—pancreatic cancer	0.000207	0.000758	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—HEY2—pancreatic cancer	0.000206	0.000968	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GAST—pancreatic cancer	0.000203	0.000953	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GAST—pancreatic cancer	0.000202	0.000946	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000201	0.000944	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AGTR1—pancreatic cancer	0.0002	0.00094	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Doxorubicin—pancreatic cancer	0.0002	0.000731	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000199	0.000933	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000195	0.000916	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Epirubicin—pancreatic cancer	0.000193	0.000707	CcSEcCtD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000193	0.000905	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SCT—pancreatic cancer	0.000193	0.000903	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HEY1—pancreatic cancer	0.000193	0.000903	CbGpPWpGaD
Tolvaptan—Body temperature increased—Doxorubicin—pancreatic cancer	0.000192	0.000702	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—HEY1—pancreatic cancer	0.000191	0.000897	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SCT—pancreatic cancer	0.000191	0.000897	CbGpPWpGaD
Tolvaptan—Asthenia—Epirubicin—pancreatic cancer	0.000188	0.000688	CcSEcCtD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000186	0.000873	CbGpPWpGaD
Tolvaptan—Pruritus—Epirubicin—pancreatic cancer	0.000185	0.000679	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—CCK—pancreatic cancer	0.000184	0.000862	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCK—pancreatic cancer	0.000182	0.000855	CbGpPWpGaD
Tolvaptan—Diarrhoea—Epirubicin—pancreatic cancer	0.000179	0.000656	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—CNR2—pancreatic cancer	0.000179	0.00084	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GLP1R—pancreatic cancer	0.000179	0.00084	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCL8—pancreatic cancer	0.000179	0.000839	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000179	0.000654	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—CNR2—pancreatic cancer	0.000178	0.000834	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GLP1R—pancreatic cancer	0.000178	0.000834	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000178	0.000833	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCKAR—pancreatic cancer	0.000176	0.000826	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCKAR—pancreatic cancer	0.000175	0.00082	CbGpPWpGaD
Tolvaptan—Asthenia—Doxorubicin—pancreatic cancer	0.000174	0.000637	CcSEcCtD
Tolvaptan—Dizziness—Epirubicin—pancreatic cancer	0.000173	0.000634	CcSEcCtD
Tolvaptan—Pruritus—Doxorubicin—pancreatic cancer	0.000172	0.000628	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—JAG2—pancreatic cancer	0.000171	0.000801	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JAG2—pancreatic cancer	0.00017	0.000795	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000169	0.000791	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MEN1—pancreatic cancer	0.000168	0.000789	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MEN1—pancreatic cancer	0.000167	0.000784	CbGpPWpGaD
Tolvaptan—Diarrhoea—Doxorubicin—pancreatic cancer	0.000166	0.000607	CcSEcCtD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000166	0.000777	CbGpPWpGaD
Tolvaptan—Headache—Epirubicin—pancreatic cancer	0.000164	0.000601	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—SHH—pancreatic cancer	0.000161	0.000753	CbGpPWpGaD
Tolvaptan—Dizziness—Doxorubicin—pancreatic cancer	0.00016	0.000587	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH4—pancreatic cancer	0.00016	0.000748	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SHH—pancreatic cancer	0.000159	0.000748	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IAPP—pancreatic cancer	0.000159	0.000744	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000158	0.000743	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IAPP—pancreatic cancer	0.000157	0.000738	CbGpPWpGaD
Tolvaptan—Nausea—Epirubicin—pancreatic cancer	0.000156	0.00057	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—PTHLH—pancreatic cancer	0.000152	0.000714	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTCH1—pancreatic cancer	0.000152	0.000714	CbGpPWpGaD
Tolvaptan—Headache—Doxorubicin—pancreatic cancer	0.000152	0.000556	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—PTHLH—pancreatic cancer	0.000151	0.000709	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTCH1—pancreatic cancer	0.000151	0.000709	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	0.000146	0.000687	CbGpPWpGaD
Tolvaptan—Nausea—Doxorubicin—pancreatic cancer	0.000144	0.000527	CcSEcCtD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000142	0.000665	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SST—pancreatic cancer	0.000139	0.000653	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SST—pancreatic cancer	0.000138	0.000648	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000137	0.000644	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000136	0.000639	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JAG1—pancreatic cancer	0.000136	0.000639	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000136	0.000636	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JAG1—pancreatic cancer	0.000135	0.000634	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000135	0.000632	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	0.000134	0.000627	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CNR1—pancreatic cancer	0.000128	0.000603	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000128	0.000602	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	0.000128	0.0006	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CNR1—pancreatic cancer	0.000128	0.000598	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	0.000125	0.000588	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000125	0.000585	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000124	0.000583	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GCG—pancreatic cancer	0.000124	0.000582	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000124	0.000581	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GCG—pancreatic cancer	0.000123	0.000578	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000122	0.000572	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000121	0.000566	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.00012	0.000562	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AGTR1—pancreatic cancer	0.000118	0.000555	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AGTR1—pancreatic cancer	0.000118	0.000551	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STK11—pancreatic cancer	0.000117	0.000547	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STK11—pancreatic cancer	0.000116	0.000543	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	0.00011	0.000514	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000109	0.00051	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	0.000109	0.000509	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000105	0.000493	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000104	0.00049	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SMAD4—pancreatic cancer	0.000102	0.000479	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SMAD4—pancreatic cancer	0.000101	0.000476	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000101	0.000474	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.0001	0.000471	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HES1—pancreatic cancer	9.98e-05	0.000468	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	9.97e-05	0.000467	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HES1—pancreatic cancer	9.91e-05	0.000465	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	9.56e-05	0.000448	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CB—pancreatic cancer	9.49e-05	0.000445	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—pancreatic cancer	9.31e-05	0.000436	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	9.25e-05	0.000434	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL8—pancreatic cancer	9.18e-05	0.000431	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL8—pancreatic cancer	9.12e-05	0.000428	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	8.86e-05	0.000415	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TERT—pancreatic cancer	8.74e-05	0.00041	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TERT—pancreatic cancer	8.68e-05	0.000407	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HIF1A—pancreatic cancer	8.36e-05	0.000392	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TSC2—pancreatic cancer	8.34e-05	0.000391	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HIF1A—pancreatic cancer	8.3e-05	0.000389	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TSC2—pancreatic cancer	8.28e-05	0.000388	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOE—pancreatic cancer	8.16e-05	0.000383	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOE—pancreatic cancer	8.1e-05	0.00038	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	8.07e-05	0.000379	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	8e-05	0.000375	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KDR—pancreatic cancer	8e-05	0.000375	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KDR—pancreatic cancer	7.94e-05	0.000372	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NFKBIA—pancreatic cancer	7.61e-05	0.000357	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NFKBIA—pancreatic cancer	7.55e-05	0.000354	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH1—pancreatic cancer	7.53e-05	0.000353	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH1—pancreatic cancer	7.48e-05	0.000351	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CG—pancreatic cancer	7.37e-05	0.000345	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—NRAS—pancreatic cancer	7.37e-05	0.000345	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CG—pancreatic cancer	7.31e-05	0.000343	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—NRAS—pancreatic cancer	7.31e-05	0.000343	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGF—pancreatic cancer	7.28e-05	0.000341	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGF—pancreatic cancer	7.23e-05	0.000339	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	6.8e-05	0.000319	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EGFR—pancreatic cancer	6.71e-05	0.000315	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EGFR—pancreatic cancer	6.66e-05	0.000312	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PRSS1—pancreatic cancer	6.63e-05	0.000311	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CD—pancreatic cancer	6.48e-05	0.000304	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CD—pancreatic cancer	6.43e-05	0.000302	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.41e-05	0.000301	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.37e-05	0.000299	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—KRAS—pancreatic cancer	6.34e-05	0.000297	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	6.31e-05	0.000296	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—KRAS—pancreatic cancer	6.29e-05	0.000295	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	6.15e-05	0.000288	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	6.09e-05	0.000285	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	5.93e-05	0.000278	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	5.83e-05	0.000273	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CA—pancreatic cancer	5.78e-05	0.000271	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ARG2—pancreatic cancer	5.75e-05	0.00027	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CB—pancreatic cancer	5.64e-05	0.000265	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CB—pancreatic cancer	5.6e-05	0.000263	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	5.5e-05	0.000258	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL8—pancreatic cancer	5.42e-05	0.000254	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HRAS—pancreatic cancer	5.39e-05	0.000253	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL8—pancreatic cancer	5.39e-05	0.000253	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	5.36e-05	0.000251	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HRAS—pancreatic cancer	5.35e-05	0.000251	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—pancreatic cancer	5.24e-05	0.000246	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—pancreatic cancer	5.2e-05	0.000244	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—pancreatic cancer	5.19e-05	0.000243	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—pancreatic cancer	5.15e-05	0.000242	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCND1—pancreatic cancer	5.05e-05	0.000237	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TYMP—pancreatic cancer	5.02e-05	0.000236	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCND1—pancreatic cancer	5.02e-05	0.000235	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CTNNB1—pancreatic cancer	5e-05	0.000235	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CTNNB1—pancreatic cancer	4.97e-05	0.000233	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	4.93e-05	0.000231	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	4.92e-05	0.000231	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—pancreatic cancer	4.91e-05	0.00023	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTEN—pancreatic cancer	4.88e-05	0.000229	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—pancreatic cancer	4.87e-05	0.000228	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTEN—pancreatic cancer	4.84e-05	0.000227	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	4.82e-05	0.000226	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—pancreatic cancer	4.76e-05	0.000223	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—pancreatic cancer	4.72e-05	0.000222	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	4.59e-05	0.000215	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	4.56e-05	0.000214	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SRC—pancreatic cancer	4.52e-05	0.000212	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SRC—pancreatic cancer	4.49e-05	0.000211	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—pancreatic cancer	4.41e-05	0.000207	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—pancreatic cancer	4.37e-05	0.000205	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—pancreatic cancer	4.36e-05	0.000205	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NRAS—pancreatic cancer	4.35e-05	0.000204	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—pancreatic cancer	4.33e-05	0.000203	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NRAS—pancreatic cancer	4.32e-05	0.000203	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.19e-05	0.000196	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PRSS1—pancreatic cancer	4.08e-05	0.000192	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MYC—pancreatic cancer	4.05e-05	0.00019	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GLP1R—pancreatic cancer	4.05e-05	0.00019	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.05e-05	0.00019	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—pancreatic cancer	4.04e-05	0.00019	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MYC—pancreatic cancer	4.02e-05	0.000189	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—pancreatic cancer	4.01e-05	0.000188	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DPYD—pancreatic cancer	3.98e-05	0.000187	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGFR—pancreatic cancer	3.96e-05	0.000186	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGFR—pancreatic cancer	3.94e-05	0.000185	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC2A2—pancreatic cancer	3.78e-05	0.000177	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KRAS—pancreatic cancer	3.75e-05	0.000176	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KRAS—pancreatic cancer	3.72e-05	0.000174	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.54e-05	0.000166	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CA—pancreatic cancer	3.44e-05	0.000161	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.42e-05	0.00016	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CA—pancreatic cancer	3.42e-05	0.00016	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—pancreatic cancer	3.33e-05	0.000156	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—pancreatic cancer	3.3e-05	0.000155	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HRAS—pancreatic cancer	3.18e-05	0.000149	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HRAS—pancreatic cancer	3.16e-05	0.000148	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.1e-05	0.000145	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CD44—pancreatic cancer	2.93e-05	0.000137	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—pancreatic cancer	2.81e-05	0.000132	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCG—pancreatic cancer	2.81e-05	0.000132	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—pancreatic cancer	2.79e-05	0.000131	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—STK11—pancreatic cancer	2.64e-05	0.000124	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.49e-05	0.000117	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.45e-05	0.000115	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.33e-05	0.000109	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TYMS—pancreatic cancer	2.27e-05	0.000106	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOE—pancreatic cancer	1.85e-05	8.66e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CD44—pancreatic cancer	1.8e-05	8.46e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCG—pancreatic cancer	1.73e-05	8.11e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.67e-05	7.81e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—STK11—pancreatic cancer	1.63e-05	7.62e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—pancreatic cancer	1.61e-05	7.54e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.46e-05	6.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.4e-05	6.56e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.28e-05	5.99e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.27e-05	5.93e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOE—pancreatic cancer	1.14e-05	5.33e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTEN—pancreatic cancer	1.1e-05	5.17e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.03e-05	4.81e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—pancreatic cancer	9.91e-06	4.65e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	9.02e-06	4.23e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	7.87e-06	3.69e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—pancreatic cancer	7.79e-06	3.66e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CA—pancreatic cancer	7.78e-06	3.65e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTEN—pancreatic cancer	6.8e-06	3.19e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—pancreatic cancer	6.36e-06	2.98e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	4.8e-06	2.25e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—pancreatic cancer	3.92e-06	1.84e-05	CbGpPWpGaD
